{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:06:00Z","timestamp":1790701560534,"version":"4.1.0"},"reference-count":26,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chongqing Medical University Program for Youth Innovation in Future Medicine","award":["W0084"],"award-info":[{"award-number":["W0084"]}],"id":[{"id":"https:\/\/ror.org\/017z00e58","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Transmembrane protein 61 (TMEM61) has previously been reported in several malignancies. However, its function in ovarian cancer remains unclear. Here, we aimed to investigate the role and underlying mechanisms of TMEM61 in ovarian cancer cells. Methods: Differentially expressed genes were identified by analyzing transcriptomic data of 426 ovarian cancer tissues from The Cancer Genome Atlas database and 88 normal ovarian tissues from the Genotype-Tissue Expression database using the web-based analytical tool GEPIA2. The effects of TMEM61 knockdown on ovarian cancer cell invasion, migration, and proliferation were evaluated using Transwell, wound healing, and Cell Counting Kit-8 assays. The effect of TMEM61 knockdown on DNA damage and cytosolic DNA accumulation was assessed using immunofluorescence and comet assays. TMEM61 and programmed death-ligand 1 (PD-L1) expression levels were assessed using immunoblotting and reverse transcription-quantitative polymerase chain reaction. Results: TMEM61 exhibited very low expression in normal ovarian tissues, but its expression was significantly upregulated in ovarian cancer tissues. TMEM61 knockdown significantly inhibited the proliferation, migration, and invasion of ovarian cancer cells; induced DNA damage and cytoplasmic DNA accumulation; and upregulated PD-L1 expression in ovarian cancer cells. Conclusions: TMEM61 promotes malignant behavior and maintains genomic stability in ovarian cancer cells. TMEM61 may serve as a potential biomarker and molecular target for ovarian cancer.<\/jats:p>","DOI":"10.31083\/fbl54612","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:21:51Z","timestamp":1790698911000},"source":"Crossref","is-referenced-by-count":0,"title":["TMEM61 Promotes Malignant Behaviors and Maintains Genomic Stability in Ovarian Cancer Cells"],"prefix":"10.31083","volume":"31","author":[{"given":"Zhizheng","family":"Dai","sequence":"first","affiliation":[{"name":"Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, 400010 Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilian","family":"Tong","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, 400010 Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6892-1207","authenticated-orcid":true,"given":"Kai-Fu","family":"Tang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, 400010 Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nature Cancer. 2023; 4: 1239\u20131257.","DOI":"10.1038\/s43018-023-00617-9"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA: a Cancer Journal for Clinicians. 2026; 76: e70043.","DOI":"10.3322\/caac.70043"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ (Clinical Research Ed.). 2020; 371: m3773.","DOI":"10.1136\/bmj.m3773"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Kandalaft LE, Dangaj Laniti D, Coukos G. Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation. Nature Reviews. Cancer. 2022; 22: 640\u2013656.","DOI":"10.1038\/s41568-022-00503-z"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Kandalaft LE, Odunsi K, Coukos G. Immunotherapy in Ovarian Cancer: Are We There Yet? Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2019; 37: 2460\u20132471.","DOI":"10.1200\/JCO.19.00508"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA: a Cancer Journal for Clinicians. 2019; 69: 280\u2013304.","DOI":"10.3322\/caac.21559"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Zhu Y, Song J, Zhu Y, Xu H, Lang S, Yang X, et al. Emerging Biomaterials Blocking PD-1\/PD-L1 Pathway for Cancer Therapy. Advanced Materials (Deerfield Beach, Fla.). 2026; 38: e17019.","DOI":"10.1002\/adma.202517019"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Ghisoni E, Morotti M, Sarivalasis A, Grimm AJ, Kandalaft L, Laniti DD, et al. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach. Nature Reviews. Clinical Oncology. 2024; 21: 801\u2013817.","DOI":"10.1038\/s41571-024-00937-4"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Zheng Y, Yang F, Wang M, Wang Z, Zhang X, Huo C, et al. Ceramide disrupts TM9SF2-PGK1 axis to redirect PD-L1 trafficking and enhance antitumor immunity. Nature Communications. 2026; 17: 4525.","DOI":"10.1038\/s41467-026-70764-x"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99: 12293\u201312297.","DOI":"10.1073\/pnas.192461099"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Mirza MR, Coleman RL, Gonz\u00e1lez-Mart\u00edn A, Moore KN, Colombo N, Ray-Coquard I, et al. The forefront of ovarian cancer therapy: update on PARP inhibitors. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2020; 31: 1148\u20131159.","DOI":"10.1016\/j.annonc.2020.06.004"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Guerra C, Kalaitsidou M, Kueberuwa G, Hawkins R, Edmondson R. Engineering strategies to optimise adoptive cell therapy in ovarian cancer. Cancer Treatment Reviews. 2023; 121: 102632.","DOI":"10.1016\/j.ctrv.2023.102632"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Marx S, Dal Maso T, Chen JW, Bury M, Wouters J, Michiels C, et al. Transmembrane (TMEM) protein family members: Poorly characterized even if essential for the metastatic process. Seminars in Cancer Biology. 2020; 60: 96\u2013106.","DOI":"10.1016\/j.semcancer.2019.08.018"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Schmit K, Michiels C. TMEM Proteins in Cancer: A Review. Frontiers in Pharmacology. 2018; 9: 1345.","DOI":"10.3389\/fphar.2018.01345"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Zhang N, Pan H, Liang X, Xie J, Han W. The roles of transmembrane family proteins in the regulation of store-operated Ca2+ entry. Cellular and Molecular Life Sciences: CMLS. 2022; 79: 118.","DOI":"10.1007\/s00018-021-04034-y"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Wang S, Zhou Q, Yan S, Liu C, Li F, Feng D, et al. TMEM17 Promotes Tumor Progression in Glioblastoma by Activating the PI3K\/AKT Pathway. Frontiers in Bioscience (Landmark Edition). 2024; 29: 285.","DOI":"10.31083\/j.fbl2908285"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Yang G, Rosen DG, Liu G, Yang F, Guo X, Xiao X, et al. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research. 2010; 16: 3875\u20133886.","DOI":"10.1158\/1078-0432.CCR-10-0483"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Luo YW, Zhou JP, Ji H, Xu D, Zheng A, Wang X, et al. SARS-CoV-2 N protein-induced Dicer, XPO5, SRSF3, and hnRNPA3 downregulation causes pneumonia. Nature Communications. 2024; 15: 6964.","DOI":"10.1038\/s41467-024-51192-1"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Chen X, Li WF, Wu X, Zhang HC, Chen L, Zhang PY, et al. Dicer regulates non-homologous end joining and is associated with chemosensitivity in colon cancer patients. Carcinogenesis. 2017; 38: 873\u2013882.","DOI":"10.1093\/carcin\/bgx059"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Pierce AJ, Johnson RD, Thompson LH, Jasin M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes & Development. 1999; 13: 2633\u20132638.","DOI":"10.1101\/gad.13.20.2633"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Kotsantis P, Petermann E, Boulton SJ. Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place. Cancer Discovery. 2018; 8: 537\u2013555.","DOI":"10.1158\/2159-8290.CD-17-1461"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Groelly FJ, Fawkes M, Dagg RA, Blackford AN, Tarsounas M. Targeting DNA damage response pathways in cancer. Nature Reviews. Cancer. 2023; 23: 78\u201394.","DOI":"10.1038\/s41568-022-00535-5"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Suptela AJ, Marriott I. Cytosolic DNA sensors and glial responses to endogenous DNA. Frontiers in Immunology. 2023; 14: 1130172.","DOI":"10.3389\/fimmu.2023.1130172"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Cheng AN, Cheng LC, Kuo CL, Lo YK, Chou HY, Chen CH, et al. Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles. Journal for Immunotherapy of Cancer. 2020; 8: e001372.","DOI":"10.1136\/jitc-2020-001372"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Wang Q, Du J, Hua S, Zhao K. TREX1 plays multiple roles in human diseases. Cellular Immunology. 2022; 375: 104527.","DOI":"10.1016\/j.cellimm.2022.104527"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Wrzesi\u0144ski T, Szelag M, Cie\u015blikowski WA, Ida A, Giles R, Zodro E, et al. Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors. BMC Cancer. 2015; 15: 518.","DOI":"10.1186\/s12885-015-1530-4"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/9\/10.31083\/FBL54612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:22:33Z","timestamp":1790698953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/9\/10.31083\/FBL54612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02263-X"],"URL":"https:\/\/doi.org\/10.31083\/fbl54612","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"54612"}}